These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32538461)

  • 21. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.
    Magnano M; Balestri R; Bardazzi F; Mazzatenta C; Girardelli CR; Rech G
    Dermatol Ther; 2020 Jul; 33(4):e13706. PubMed ID: 32475056
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 and exacerbation of dermatological diseases: A review of the available literature.
    Aram K; Patil A; Goldust M; Rajabi F
    Dermatol Ther; 2021 Nov; 34(6):e15113. PubMed ID: 34453380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
    Kutlu Ö; Metin A
    Dermatol Ther; 2020 Jul; 33(4):e13509. PubMed ID: 32367558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.
    Armesto S; González Vela C; González López MA
    Dermatol Ther; 2020 Jul; 33(4):e13618. PubMed ID: 32424891
    [No Abstract]   [Full Text] [Related]  

  • 26. Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.
    Kado S; Kamiya K; Kishimoto M; Maekawa T; Kuwahara A; Sugai J; Komine M; Ohtsuki M
    J Dermatol; 2021 Dec; 48(12):1907-1912. PubMed ID: 34549456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsoriatic treatments during COVID-19 outbreak.
    Di Lernia V
    Dermatol Ther; 2020 Jul; 33(4):e13345. PubMed ID: 32223073
    [No Abstract]   [Full Text] [Related]  

  • 28. Comment on "Antipsoriatic treatments during COVID-19 outbreak".
    Abdelmaksoud A; Goldust M; Vestita M
    Dermatol Ther; 2020 Jul; 33(4):e13491. PubMed ID: 32358882
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.
    Sadeghinia A; Daneshpazhooh M
    Dermatol Ther; 2021 Jan; 34(1):e14498. PubMed ID: 33141519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covid-19 infection in psoriasis patients treated with cyclosporin.
    Di Lernia V; Goldust M; Feliciani C
    Dermatol Ther; 2020 Jul; 33(4):e13739. PubMed ID: 32478942
    [No Abstract]   [Full Text] [Related]  

  • 31. A Lesson Not To Be Forgotten. Ophthalmologists in Northern Italy Become Internists During the SARS-CoV-2 Pandemic.
    Starace V; Brambati M; Battista M; Capone L; Gorgoni F; Cavalleri M; di Biase C; Grazioli Moretti A; Pederzolli M; Grosso D; Nadin F; di Matteo F; Fiori M; Bandello F
    Am J Ophthalmol; 2020 Dec; 220():219-220. PubMed ID: 32624166
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of prurigo pigmentosa occurring in a patient with psoriasis vulgaris following a ketogenic diet during the COVID-19 pandemic.
    Oku A; Nakai K; Tsuruta D
    Int J Dermatol; 2021 Nov; 60(11):1437-1438. PubMed ID: 34363697
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 in an elderly patient treated with secukinumab.
    Di Lernia V; Bombonato C; Motolese A
    Dermatol Ther; 2020 Jul; 33(4):e13580. PubMed ID: 32406078
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course.
    Yalici-Armagan B; Tabak GH; Dogan-Gunaydin S; Gulseren D; Akdogan N; Atakan N
    J Cosmet Dermatol; 2021 Oct; 20(10):3098-3102. PubMed ID: 34365714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of psoriasis - unburdened by fear during SARS-CoV2 menace.
    Timis TL; Florian IA; Vesa SC; Orasan RI
    J Dermatolog Treat; 2022 Mar; 33(2):662-665. PubMed ID: 32594821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of COVID-19 on Italy: A Lesson for the Future.
    Santacroce L; Bottalico L; Charitos IA
    Int J Occup Environ Med; 2020 Jul; 11(3):151-152. PubMed ID: 32225178
    [No Abstract]   [Full Text] [Related]  

  • 37. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study.
    Oguz Topal I; Kara Polat A; Zindancı İ; Kıvanç Altunay İ; Akbulut TÖ; Arıkan EE; Topaloğlu Demir F; Sivaz O; Karadağ AS
    J Cosmet Dermatol; 2022 Jan; 21(1):39-47. PubMed ID: 34792848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive treatment for systemic sclerosis-Therapeutic challenges during the COVID-19 pandemic.
    Blicharz L; Czuwara J; Samochocki Z; Goldust M; Olszewska M; Rudnicka L
    Dermatol Ther; 2020 Jul; 33(4):e13619. PubMed ID: 32428315
    [No Abstract]   [Full Text] [Related]  

  • 39. SARS-CoV-2 infection in pregnancy during the first wave of COVID-19 in the Netherlands: a prospective nationwide population-based cohort study (NethOSS).
    Overtoom EM; Rosman AN; Zwart JJ; Vogelvang TE; Schaap TP; van den Akker T; Bloemenkamp K
    BJOG; 2022 Jan; 129(1):91-100. PubMed ID: 34494694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.